Blood nicotine and carboxyhaemoglobin (COHb) 
Introduction
The hazards of cigarette smoking are widely believed to be reduced by lowering the tar and nicotine yields of cigarettes. '-4 Many countries now publish official tables listing the yields, and various approaches have been considered to discourage the manufacture and use of high-tar brands. In Britain, for example, a supplementary tax was introduced in 1978 on cigarettes in the "high tar" category (29 mg and over).
This official "low-tar, low-nicotine" approach to safer cigarettes is based on two related assumptions: (i) that the amount of smoke taken in by smokers is largely determined by the standardised machine-smoked yields of the cigarettes; and (ii) that in consequence changing to lower-tar brands will result in roughly proportionate reductions in intake. The smoking C FEYERABEND, BSc, biochemist patterns of people, however, do not mirror those of the smoking machine. Individuals vary widely in how they puff and inhale, and, more importantly, unlike the machine, when switching brands they tend to modify their smoking pattern to maintain their intake of smoke at a fairly constant level.5-12 It is important, therefore, to know to what extent the benefit of switching to lower-tar cigarettes is offset by the tendency of smokers to compensate by smoking more cigarettes or increasing inhalation. Since 1974 we have been measuring blood nicotine and carboxyhaemoglobin (COHb) concentrations in smokers attending our smokers' clinic and in volunteers taking part in various experimental studies on smoking behaviour. This has provided data that have enabled us to examine the relation of the blood nicotine concentrations in smokers to the type of cigarettes they smoke.
Subjects and methods
Data on smoking habits and blood nicotine and COHb concentrations were available from 212 women and 151 men who attended the Maudsley Hospital smokers' clinic or volunteered for experimental studies on smoking at the addiction research unit. We excluded those who smoked cigars or hand-rolled cigarettes, leaving 206 women and 124 men who regularly smoked manufactured cigarettes for which tar and nicotine yields were available from the official tables published by the Department of Health. Carbon monoxide (CO) yields, though measured by the Govemment Chemist, were withheld by the Department of Health. The Tobacco Advisory Council, however, provided data on CO yields of some brands.
All subjects attended in the afternoon and had been instructed to smoke their usual brand in their usual way. On arrival they were asked to smoke one of their usual cigarettes, and a venous blood sample was taken two minutes after they had finished it. The samples were analysed for COHb by using an IL 182 CO-oximeter,13 and plasma nicotine concentration was measured by gas chromatography.14 Results Figure 1 shows the blood nicotine concentration in each subject according to the type of cigarette smoked and its nicotine yield. The plain cigarettes, with nicotine yields of 1-7 mg or more, were all in the "middle to high tar" group (23-28 mg tar/cigarette) or "high tar" group (29 mg or more/cigarette) in the Government tables. Cigarettes with unventilated filters yielding 1-2-17 mg nicotine were mostly in the "middle tar" group (17-22 mg/cigarette), though some were in the "low to middle tar" group (11-16 mg/cigarette). Most of the cigarettes with nicotine yields of 0-9 mg or less were from the "low tar" group (<10 mg/cigarette). None of our subjects smoked the four brands available on the British market with nicotine yields below 0 6 mg/cigarette.
Blood nicotine concentrations varied widely and bore little relation to the nicotine yields of the cigarettes, although there was a small positive relation between the two variables (r=0 26 in the women 
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(p<O-001); r=0 17 in the men (p<003)). Concentrations were similar in the men and the women (fig 1, table I ), despite the higher daily cigarette consumption of the men.
Of the variables measured, the nicotine yield of the cigarette was the main determinant of blood nicotine concentration, but its contribution was small. Cigarette consumption contributed even less. Table III shows that the nicotine yield of cigarettes together with cigarette consumption accounted for only 6-5% of the variance in blood nicotine concentrations. Consumption on the day of study was a better predictor than average daily consumption. The positive correlation of tar yield with blood nicotine concentration was largely due to the correlation between tar and nicotine yields, but the negative beta coefficient shows that tar yield had an independent negative relation to blood nicotine concentration. Table IV shows the blood nicotine and COHb concentrations in smokers of plain cigarettes, cigarettes with unventilated filter tips, and cigarettes with ventilated filter tips. Despite large differences in the machine-smoked yields of the different types of cigarette the blood concentrations in the smokers were not significantly different. This comparison, however, is marred by the overlap in the nicotine yields of these three types of cigarette ( fig 1) ; it also takes no account of the size of the cigarettes (king size, standard, and small).
RELATION OF BLOOD NICOTINE AND COHb CONCENTRATIONS TO TYPE OF CIGARETTE
To gain some idea of how the nicotine and CO intake of the smoking cigarettes, and blood nicotine and COHb concentrations in all subjects (men below Figure 2 shows the blood nicotine and COHb concentrations in these three groups.
The mean blood nicotine concentrations were 203, 209, and 231 nmol/l (32-9, 33.9, and 37-4 ng/ml) in the men smoking ventilated filter, unventilated filter, and plain cigarettes respectively; these values were not significantly different (F=0-6, df=2/28-analysis of variance for matched groups'5), despite the large differences in nicotine yields (0-81, 1-30, and 1-96 mg respectively). Mean COHb concentrations were significantly different between the three groups, being 8- 
Discussion
Two things should be borne in mind when considering the results of this study. Firstly, the sample did not represent normal smokers in the population, but consisted of heavy smokers whose average daily consumption was double that of the general population. '6 The proportion who usually smoked a low-nicotine brand ( <1 0 mg) was also about double the 12 % found in the general population. The sample thus consisted of exceptionally heavy smokers, most of whom were seeking treatment to help them give up smoking and whose high rate of use of low-nicotine cigarettes was probably an indication of their greater concern for the health risks of smoking. Secondly, their brand of cigarette was self-selected in the sense that it was not forced on them as part of an experiment. In addition, most of those using a lownicotine brand had been doing so for at least a year. It is well known that plain cigarettes are used mainly by men and that daily cigarette consumption is higher in men than women. '8 Our study confirmed this. We are not aware, however, of previous studies comparing blood nicotine and COHb concentrations in men and women smokers. The blood nicotine concentrations were strikingly similar and averaged 203 nmol/l (33 ng/ml) in both men and women despite the higher consumption of the men. When the smokers of plain cigarettes were excluded there were no significant differences in COHb concentrations between the men and women, nor in the average tar and nicotine yields of the cigarettes smoked. Clearly then, among these heavy smokers the inhaling habits of men and women were similar. The higher consumption by men might be due to their greater body weight or possibly to an economic factor, but it is not known why men are more inclined to use plain cigarettes.
RELATION OF INTAKE BY SMOKER TO YIELD AND NUMBER OF CIGARETTES SMOKED
Peak blood nicotine concentrations in individual smokers varied widely-from 25 to 444 nmol/l (4 to 72 ng/ml) around the mean of 203 nmol/l (33 ng/ml)-but bore little relation to the number of cigarettes smoked, the type of cigarette, or its tar and nicotine yield. Many smokers achieved high blood nicotine concentrations from low-nicotine cigarettes, and many smokers of high-nicotine cigarettes had low blood nicotine concentrations. Despite the large differences in nicotine yields, average blood nicotine concentrations were similar in smokers of plain cigarettes (mean yield 19 mg nicotine/cigarette), cigarettes with unventilated filters (mean nicotine yield 1-3 mg), and cigarettes with ventilated filters (mean nicotine yield 0 8 mg). The correlation between blood nicotine concentration and nicotine yield of cigarette, though significant, was low (0 21 for men and women combined, p <0 001), showing that the nicotine yield of the cigarettes accounted for only 4-40o of the variation in blood nicotine concentrations.
The longer half life of COHb (two to three hours)5 17 makes it a better marker of overall smoke intake over the course of a day. Peak blood nicotine concentration is determined more by the intake from the preceding cigarette.18 This difference is reflected in the correlations with cigarette consumption, which, though low, were higher for COHb than for blood nicotine. Even with COHb the correlation with cigarette consumption was only 0 3 and indicates that the number of cigarettes smoked accounted for only 90 of the variation in the amount of smoke taken into the lungs.
If the Department of Health had allowed us access to their data on CO yields of cigarettes we could have related these more systematically to the COHb concentration. Nevertheless, our findings are similar to those of Wald et all" in showing a tendency for COHb concentrations to be slightly lower in smokers of plain cigarettes (mean 6-30%) than in smokers of filter-tipped cigarettes (8 0%o and 7 80 for unventilated and ventilated filters respectively). This is partly due to the slightly lower CO yields of plain cigarettes but more particularly because plain cigarettes are inhaled less deeply.20 The similar COHb concentrations in smokers of cigarettes with ventilated and unventilated filters despite the lower CO yields of the former (12 mg v 19 mg CO per cigarette '9) indicates that the smokers of cigarettes with ventilated filters inhaled more deeply.
IMPLICATIONS FOR LESS HAZARDOUS CIGARETTES
This study showed that cigarette consumption, tar and nicotine yield of cigarettes, and the type of cigarette made little difference and accounted for little of the variance in blood nicotine and COHb concentrations. This suggests that the smoke intake of smokers is largely determined by their individual pattern of puffing and inhaling and that the assumed health advantage of smoking cigarettes with lower machine-smoked tar and nicotine yields is mostly offset by the tendency of smokers to modify their smoking pattern to regulate their intake to a fairly constant level. Moreover, the small tendency for smokers of lower-nicotine cigarettes to have lower blood nicotine concentrations might partly have occurred because the subjects selected their own brand of cigarettes. For instance, the smokers who had chosen lower-nicotine brands might possibly have tended to be those with slightly lower blood nicotine concentrations before they changed brands; and this factor, rather than any reduction in intake after changing, might have contributed to the low correlations observed between blood nicotine concentration and nicotine yield of cigarette. Owing to the high correlation of tar and nicotine yields we cannot say from this study whether the self-regulation of smoke intake is mediated by a desire for a constant intake of nicotine or tar or by some other factor. Whatever its cause, our results suggest that switching to cigarettes with lower tar and nicotine yields may not reduce tar and nicotine intake at all, or at most by a disappointingly small degree.
Epidemiological studies have shown that the incidence of lung cancer and changes in the bronchial epithelium are reduced in smokers who have smoked filter-tipped rather than plain cigarettes." '5 It has been widely assumed that this is due to a reduced tar intake. Our data, however, suggest that nicotine and hence tar intake is unlikely to be appreciably reduced by a switch from plain to filter-tipped cigarettes. How Can insulin-treated diabetics be given beta-adrenergic blocking drugs? ANTHONY H BARNETT, DAVID LESLIE, PETER J WATKINS Summary and conclusions Lack of awareness of hypoglycaemia leading to loss of consciousness is a serious problem in some insulintreated diabetics, and beta-blocking drugs may increase this hazard. A prospective study was therefore carried out over eight months to determine the incidence of hypoglycaemic episodes in 50 insulin-treated diabetics taking beta-blockers as compared with 100 diabetic controls matched for age, sex, and duration of diabetes. The incidence of loss of consciousness from hypoglycaemia was the same in both groups and was unrelated to the dose of beta-blocking drug used. Five patients taking beta-blockers and 10 controls had episodes of unconsciousness, but four of these patients taking betablockers had had similar episodes in the two years preceding treatment.
It is concluded that beta-blocking drugs are generally safe in insulin-treated diabetics and that hypoglycaemic unconsciousness resulting from their use is rare. Introduction Beta-adrenergic blocking agents are an important advance in the management of hypertension and ischaemic heart disease. Concern has been expressed, however, about using these agents in insulin-treated diabetics because they might possibly reduce or eliminate the warning symptoms of hypoglycaemia, which are partly due to adrenergic stimulation. Hypoglycaemic loss of consciousness has been reported in an insulin-dependent diabetic taking beta-blocking drugs,' but the extent of this problem is unknown.
We conducted a prospective investigation to discover the incidence of unconsciousness from hypoglycaemia in insulintreated diabetics receiving beta-blocking drugs compared with matched controls.
Patients and methods
We studied for eight months 50 insulin-treated diabetics taking beta-adrenergic blocking drugs. Forty-three were taking noncardioselective drugs and seven cardioselective drugs (acebutalol or metoprolol). Thirty-six of the patients were being treated for hypertension, 10 for angina, two for arrhythmias, and two for anxiety. One hundred insulin-treated diabetics who were not taking betablocking drugs served as controls and were selected consecutively to match for age, sex, and duration of diabetes.
The patients were each given a diary card on which to record details of episodes that they considered to be hypoglycaemic. We kept a separate card to record the details of each patient and the nature of each hypoglycaemic episode. Particular attention was paid
